Omega Fund Management, LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 35 filers reported holding TRANSLATE BIO INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Omega Fund Management, LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q1 2020$24,303,000
+22.5%
2,437,6030.0%10.06%
+59.2%
Q4 2019$19,842,000
-17.9%
2,437,6030.0%6.32%
-15.3%
Q3 2019$24,157,000
-21.5%
2,437,6030.0%7.46%
-5.0%
Q2 2019$30,787,000
-38.0%
2,437,603
-50.0%
7.85%
-25.2%
Q1 2019$49,678,000
+171.7%
4,875,206
+100.0%
10.50%
-22.5%
Q4 2018$18,282,000
-25.0%
2,437,603
+0.0%
13.56%
+17.5%
Q3 2018$24,376,000
-20.9%
2,437,6010.0%11.53%
-49.3%
Q2 2018$30,836,0002,437,60122.75%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2018
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 1,872,115$30,871,0005.70%
FRAZIER MANAGEMENT LLC 2,182,789$35,994,0002.89%
Baupost Group 18,044,239$295,810,0002.36%
RTW INVESTMENTS, LP 4,382,199$72,262,0001.13%
DAFNA Capital Management LLC 225,393$3,717,0000.88%
Camber Capital Management LP 1,150,000$18,964,0000.65%
EcoR1 Capital, LLC 596,900$9,843,0000.44%
Alpha Paradigm Partners, LLC 50,393$831,000,0000.32%
Birchview Capital, LP 30,000$495,0000.29%
Artal Group S.A. 1,000,000$16,490,0000.29%
View complete list of TRANSLATE BIO INC shareholders